JPWO2020028290A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020028290A5 JPWO2020028290A5 JP2021505721A JP2021505721A JPWO2020028290A5 JP WO2020028290 A5 JPWO2020028290 A5 JP WO2020028290A5 JP 2021505721 A JP2021505721 A JP 2021505721A JP 2021505721 A JP2021505721 A JP 2021505721A JP WO2020028290 A5 JPWO2020028290 A5 JP WO2020028290A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- pharmaceutical composition
- spa
- concentration
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862713061P | 2018-08-01 | 2018-08-01 | |
| US62/713,061 | 2018-08-01 | ||
| PCT/US2019/044023 WO2020028290A1 (en) | 2018-08-01 | 2019-07-30 | Methods for treating neurodegenerative disorders |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021533128A JP2021533128A (ja) | 2021-12-02 |
| JP2021533128A5 JP2021533128A5 (https=) | 2022-08-04 |
| JPWO2020028290A5 true JPWO2020028290A5 (https=) | 2022-08-04 |
| JP7573512B2 JP7573512B2 (ja) | 2024-10-25 |
Family
ID=67614642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021505721A Active JP7573512B2 (ja) | 2018-08-01 | 2019-07-30 | 神経変性障害を治療するための方法 |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US12083082B2 (https=) |
| EP (1) | EP3829563B1 (https=) |
| JP (1) | JP7573512B2 (https=) |
| KR (1) | KR102716959B1 (https=) |
| CN (1) | CN112867485A (https=) |
| AU (1) | AU2019315853B2 (https=) |
| BR (1) | BR112021001739A2 (https=) |
| CL (1) | CL2021000269A1 (https=) |
| DK (1) | DK3829563T3 (https=) |
| EA (1) | EA202190406A1 (https=) |
| ES (1) | ES3011716T3 (https=) |
| FI (1) | FI3829563T3 (https=) |
| HR (1) | HRP20250206T1 (https=) |
| HU (1) | HUE070101T2 (https=) |
| IL (1) | IL280424B2 (https=) |
| LT (1) | LT3829563T (https=) |
| MX (1) | MX2021001287A (https=) |
| MY (1) | MY206530A (https=) |
| PH (1) | PH12021550213A1 (https=) |
| PL (1) | PL3829563T3 (https=) |
| PT (1) | PT3829563T (https=) |
| RS (1) | RS66516B1 (https=) |
| SG (1) | SG11202100767XA (https=) |
| SI (1) | SI3829563T1 (https=) |
| SM (1) | SMT202500080T1 (https=) |
| UA (1) | UA130011C2 (https=) |
| WO (1) | WO2020028290A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021025504A2 (pt) * | 2019-06-17 | 2022-04-26 | Alzheon Inc | Métodos para tratar distúrbios neurodegenerativos |
| MX2024007070A (es) * | 2021-12-09 | 2024-08-22 | Alzheon Inc | Alz-801 para uso en el tratamiento de la enfermedad de alzheimer. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5840294A (en) | 1993-03-29 | 1998-11-24 | Queen's University At Kingston | Method for treating amyloidosis |
| PT2089417E (pt) | 2006-10-12 | 2015-04-14 | Bhi Ltd Partnership | Métodos, compostos, composições e veículos para administrar o ácido 3-amino-1-propanossulfónico |
| WO2013177367A2 (en) | 2012-05-23 | 2013-11-28 | The Johns Hopkins University | Compounds and methods of use thereof for treating neurodegenerative disorders |
| WO2014121083A1 (en) | 2013-01-31 | 2014-08-07 | President And Fellows Of Harvard College | Methods of increasing neuronal connectivity and/or treating a neurodegenerative condition |
| CA2941415A1 (en) * | 2014-03-21 | 2015-09-24 | Alzheon, Inc. | Methods for treating neurological disorders |
| FI3347002T3 (fi) | 2015-09-10 | 2023-08-10 | Alzheon Inc | Alzheimerin taudin hoitaminen tietyssä potilaspopulaatiossa |
-
2019
- 2019-07-30 JP JP2021505721A patent/JP7573512B2/ja active Active
- 2019-07-30 HU HUE19752795A patent/HUE070101T2/hu unknown
- 2019-07-30 SG SG11202100767XA patent/SG11202100767XA/en unknown
- 2019-07-30 FI FIEP19752795.5T patent/FI3829563T3/fi active
- 2019-07-30 CN CN201980064415.6A patent/CN112867485A/zh active Pending
- 2019-07-30 SM SM20250080T patent/SMT202500080T1/it unknown
- 2019-07-30 US US17/264,477 patent/US12083082B2/en active Active
- 2019-07-30 EA EA202190406A patent/EA202190406A1/ru unknown
- 2019-07-30 EP EP19752795.5A patent/EP3829563B1/en active Active
- 2019-07-30 BR BR112021001739-9A patent/BR112021001739A2/pt unknown
- 2019-07-30 RS RS20250164A patent/RS66516B1/sr unknown
- 2019-07-30 PT PT197527955T patent/PT3829563T/pt unknown
- 2019-07-30 AU AU2019315853A patent/AU2019315853B2/en active Active
- 2019-07-30 WO PCT/US2019/044023 patent/WO2020028290A1/en not_active Ceased
- 2019-07-30 IL IL280424A patent/IL280424B2/en unknown
- 2019-07-30 KR KR1020217005803A patent/KR102716959B1/ko active Active
- 2019-07-30 MY MYPI2021000515A patent/MY206530A/en unknown
- 2019-07-30 DK DK19752795.5T patent/DK3829563T3/da active
- 2019-07-30 LT LTEPPCT/US2019/044023T patent/LT3829563T/lt unknown
- 2019-07-30 ES ES19752795T patent/ES3011716T3/es active Active
- 2019-07-30 PL PL19752795.5T patent/PL3829563T3/pl unknown
- 2019-07-30 SI SI201930898T patent/SI3829563T1/sl unknown
- 2019-07-30 HR HRP20250206TT patent/HRP20250206T1/hr unknown
- 2019-07-30 MX MX2021001287A patent/MX2021001287A/es unknown
- 2019-07-30 UA UAA202101015A patent/UA130011C2/uk unknown
-
2021
- 2021-01-28 PH PH12021550213A patent/PH12021550213A1/en unknown
- 2021-02-01 CL CL2021000269A patent/CL2021000269A1/es unknown
-
2024
- 2024-08-02 US US18/793,452 patent/US20250213507A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bitan et al. | Elucidation of primary structure elements controlling early amyloid β-protein oligomerization | |
| RU2152399C2 (ru) | Комплекс, содержащий аналог человеческого инсулина, и фармацевтическая композиция на его основе | |
| JP2999579B2 (ja) | Ｄｎａおよびその用途 | |
| JP7126940B2 (ja) | 補体活性のモジュレーター | |
| JP2003510368A (ja) | 安定化された液体のポリペプチド含有薬学的組成物 | |
| CN1599618A (zh) | 低氧诱导因子(HIF)α的稳定化 | |
| EP0546054A1 (en) | LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF | |
| JP2009542611A (ja) | アルファ−シヌクレイン凝集の阻害 | |
| JP2021533128A5 (https=) | ||
| JP2004521123A5 (https=) | ||
| KR20190141163A (ko) | C5 결합이 없는 코버신(coversin) 변이체 | |
| Jeppsson et al. | Blood-brain barrier derangement in uremic encephalopathy | |
| JPWO2020028290A5 (https=) | ||
| TW200410681A (en) | Amino acid compound for improving central function | |
| TW202426050A (zh) | 穩定抗體組合物 | |
| JP2873493B2 (ja) | 血糖調節剤 | |
| JP7573512B2 (ja) | 神経変性障害を治療するための方法 | |
| TH2101000540A (th) | องค์ประกอบทางเภสัชกรรมที่ประกอบรวมด้วยกรดซัลโฟโพรพาโนอิกสำหรับการผลิตยาสำหรับการรักษาความผิดปกติที่เกิดจากความเสื่อมของระบบประสาท | |
| WO2012010799A1 (fr) | Formulation d'anticorps anti-cd20 | |
| JP6710416B2 (ja) | 炎症性皮膚疾患の予防又は治療剤 | |
| US20140256629A1 (en) | Use of epo-derived peptide fragments for the treatment of neurodegenerative disorders | |
| JP2916947B2 (ja) | Ｃｐｂ―ｉの安定化方法及び製剤組成物 | |
| FR2736266A1 (fr) | Inhibiteur de l'agregation plaquettaire et procede pour preparer celui-ci | |
| JP2025533238A (ja) | 液体ダルババンシン組成物 | |
| AU2017378976A1 (en) | Methods of administering hepcidin |